AI tool helps predict who will benefit from focal therapy for prostate cancer

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most likely to benefit from partial gland cryoablation, a minimally invasive procedure that treats localized prostate tumors.

Leave A Comment

Your email address will not be published. Required fields are marked *